Previous Section
Stem Cell Transplantation
11. The role of stem cell source in autologous hematopoietic stem cell transplantation for patients with myelodysplastic syndromes.
- Author
- de Witte T; Brand R; van Biezen A; Delforge M; Biersack H; Or R; Meloni G; Bandini B; Sierra J; Kroger N; Gratwohl A; Niederwieser D;
- Institution
- Dept. of Hematology, Radboud University Medical Center Nijmegen, The Netherlands.
- Journal
- Haematologica. 2006 Jun;91(6):750-6.
- Abstract URL
- Click here to view abstract
12. Hemopoietic cell transplantation as curative therapy of myelodysplastic syndromes and myeloproliferative disorders.
- Author
- Scott B; Deeg HJ;
- Institution
- Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, D1-100, P.O. Box 19024, Seattle, WA 98109-1024, USA.
- Journal
- Best Pract Res Clin Haematol. 2006;19(3):519-33.
- Abstract URL
- Click here to view abstract
13. Successful rapid discontinuation of immunosuppressive therapy at molecular relapse after allogeneic bone marrow transplantation in a pediatric patient with myelodysplastic syndrome.
- Author
- Tamura K; Kanazawa T; Suzuki M; Koitabashi M; Ogawa C; Morikawa A;
- Institution
- Department of Pediatrics and Developmental Medicine, Gunma University Graduate School, Maebashi, Japan. ktamura@med.gunma-u.ac.jp
- Journal
- Am J Hematol. 2006 Feb;81(2):139-41.
- Abstract URL
- Click here to view abstract
14. Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis.
- Author
- Scott BL; Sandmaier BM; Storer B; Maris MB; Sorror ML; Maloney DG; Chauncey TR; Storb R; Deeg HJ;
- Institution
- Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA
- Journal
- Leukemia. 2006 Jan;20(1):128-35.
- Abstract URL
- Click here to view abstract
15. Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome.
- Author
- Kroger N; Brand R; van Biezen A; Cahn JY; Slavin S; Blaise D; Sierra J; Zander A; Niederwieser D; de Witte T;
- Institution
- Bone Marrow Transplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany. nkroeger@uke.uni-hamburg.de
- Journal
- Bone Marrow Transplant. 2006 Jan;37(2):183-9.
- Abstract URL
- Click here to view abstract
16. Long-term remissions in patients with myelodysplastic syndrome and secondary acute myelogenous leukemia undergoing allogeneic transplantation following a reduced intensity conditioning regimen of 550 cGy total body irradiation and cyclophosphamide.
- Author
- Hallemeier CL; Girgis MD; Blum WG; Brown RA; Khoury HJ; Devine SM; Vij R; Lin HS; DiPersio JF; Adkins DR; Hallemeier CL; Girgis MD; Blum WG; Brown RA; Khoury HJ; Devine SM; Vij R; Lin HS; DiPersio JF; Adkins DR;
- Institution
- Department of Internal Medicine, Division of Oncology, Section of Bone Marrow Transplantation and Leukemia, St Louis, Missouri, USA.
- Journal
- Biol Blood Marrow Transplant. 2006 Jul;12(7):749-57.
- Abstract URL
- Click here to view abstract
17. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation.
- Author
- Armand P; Kim HT; Cutler CS; Ho VT; Koreth J; Alyea EP; Soiffer RJ; Antin JH;
- Institution
- Journal
- Blood. 2007 May 15;109(10):4586-8. Epub 2007 Jan 18.
- Abstract URL
- Click here to view abstract
18. Total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine as a conditioning regimen in allogeneic hematopoietic stem cell transplantation for advanced myelodysplastic syndrome: a single-institute experience.
- Author
- Mori T; Aisa Y; Yokoyama A; Nakazato T; Yamazaki R; Shimizu T; Mihara A; Kato J; Watanabe R; Takayama N; Ikeda Y; Okamoto S;
- Institution
- Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan. tmori@sc.itc.keio.ac.jp
- Journal
- Bone Marrow Transplant. 2007 Feb;39(4):217-21. Epub 2007 Jan 15.
- Abstract URL
- Click here to view abstract
